트레드밀 운동이 파킨슨 유도 모델 쥐의 α-synuclein 발현과 미토콘드리아 구조적 역동성에 미치는 영향

키워드

참고문헌 (44)

1. Hirsch MA, "The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson’s disease", Archives of Physical Medicine and Rehabilitation, 84(8), pp.1109~1117 (2003)
2. Pringsheim T, "The prevalence of Parkinson’s disease: a systematic review and meta-analysis", Movement Disorder, 29(13), pp.1583~1590 (2014)
3. Schapira AH, "Aetiopathogenesis of Parkinson’s disease", Journal of Neurology, 258(Suppl 2), pp.S307~S310 (2011)
4. Murphy DD, "Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons", The Journal of Neuroscience, 20(9), pp.3214~3220 (2000)
5. Fortin DL, "Neural activity controls the synaptic accumulation of alpha-synuclein", The Journal of Neuroscience, 25(47), pp.10913~10921 (2005)
6. Chu Y, "Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease", Brain, 135(Pt 7), pp.2058~2073 (2012)
7. Martin LJ, "Mitochondrial permeability transition pore regulates Parkinson’s disease development in mutant α-synuclein transgenic mice", Neurobiology of Aging, 35(5), pp.1132~1152 (2014)
8. Roberts HL, "Seeking a mechanism for the toxicity of oligomeric α-synuclein", Biomolecules, 5(2), pp.282~305 (2015)
9. Winner B, "In vivo demonstration that alpha-synuclein oligomers are toxic", Proceeding of National Academy of Science of the United States of America, 108(10), pp.4194~4199 (2011)
10. Bender A, "TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson’s disease", PLoS One, 8(4), pp.e62277~ (2013)
11. Chen H, "Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases", Human Molecular Genetics, 18(R2), pp.R169~R176 (2009)
12. Xie W, "Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease", Journal of Neurochemistry, 122(2), pp.404~414 (2012)
13. Kamp F, "Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1", The EMBO Jorunal, 29(20), pp.3571~3589 (2010)
14. Gui YX, "Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1", Neurobiology of Aging, 33(12), pp.2841~2854 (2012)
15. Nakamura K, "Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein", The Journal of Biological Chemistry, 286(23), pp.20710~20726 (2011)
16. Hüttenrauch M, "Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model", Translational Psychiatry, 6(5), pp.e800~ (2016)
17. Li L, "Moderate exercise prevents neurodegeneration in D-galactose-induced aging mice", Neural Regeneration Research, 11(5), pp.807~815 (2016)
18. Yan Z, "Exercise training-induced regulation of mitochondrial quality", Exercise and Sport Scienece Reviews, 40(3), pp.159~164 (2012)
19. Smith BA, "Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse", Brain Research, 1386, pp.70~80 (2011)
20. Real CC, "BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson’s disease", Neuroscience, 237, pp.118~129 (2013)
21. Tuon T, "Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson’s disease", Brain Research Bulletin, 108, pp.106~112 (2014)
22. Tuon T, "Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease", Neuroscience, 227, pp.305~312 (2012)
23. Lau YS, "Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration", The Euroupean Journal of Neuroscience, 33(7), pp.1264~1274 (2011)
24. Mandel S, "Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs Rapomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate", Journal of Molecular Neuroscience, 24(3), pp.401~416 (2004)
25. Meredith GE, "Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol", Parkinsonism & Related Disorders, 14(Suppl 2), pp.S112~S115 (2008)
26. Kowall NW, "MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons", Neuroreport, 11(1), pp.211~213 (2000)
27. Chen M, "Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys", Neuroscience, 286, pp.383~392 (2015)
28. Li XH, "7, 8-dihydroxyflavone Ameliorates motor deficits via suppressing α-synuclein expression and oxidative stress in the MPTP-induced mouse model of parkinson’s disease", CNS Neuroscience & Therapeutics, 22(7), pp.617~624 (2016)
29. Liu L, "Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson’s disease", Behavioural Brain Research, 281, pp.215~221 (2015)
30. Klein C, "Physical exercise counteracts MPTP-induced changes in neural precursor cell proliferation in the hippocampus and restores spatial learning but not memory performance in the water maze", Behavioural Brain Research, 307, pp.227~238 (2016)
31. Shin MS, "Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson’s disease", Neuroscience Letters, 621, pp.28~233 (2016)
32. Fornai F, "Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein", Proceeding of the National Academy of Science of United States of America, 102(9), pp.3413~3418 (2005)
33. Shioda N, "FABP3protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity", The Journal of Biological Chemistry, 289(27), pp.18957~18965 (2014)
34. Heng Y, "Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTPprobenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra", Toxicology Letters, 243, pp.7~21 (2016)
35. Requejo-Aguilar R, "Mitochondrial control of cell bioenergetics in Parkinson’s disease", Free Radical Biology & Medicine, (16), pp.S0891~S5849 (2016)
36. Von Stockum S, "Mitochondrial dynamics and mitophagy in Parkinson’s disease: A fly point of view", Neurobiology of Disease, 90, pp.58~67 (2016)
37. Westermann B, "Mitochondrial fusion and fission in cell life and death. Nature Reviews", Molecular Cell Biology, 11(12), pp.872~884 (2010)
38. Chan DC, "Mitochondrial fusion and fission in mammals", Annual Review of Cell and Development Biology, 22, pp.79~99 (2006)
39. Duan W, "Sirtuins: from metabolic regulation to brain aging", Frontiers in Aging Neuroscience, 5, pp.36~ (2013)
40. Kincaid B, "Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration", Frontiers in Aging Neuroscience, 5, pp.48~ (2013)
41. Morigi M, "Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury", The Journal of Clinical Investigation, 125(2), pp.715~726 (2015)
42. Samant SA, "SIRT3deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress", Molecular and Cell Biology, 34(5), pp.807~819 (2014)
43. Young JS, "Synchrony between sensory and cognitive networks is associated with subclinical variation in autistic traits", Frontier in Human Neuroscience, 9, pp.146~ (2015)
44. Vargas-Ortiz K, "Aerobic training increases expression levels of SIRT3 and PGC-1α in skeletal muscle of overweight adolescents without change in caloric intake", Pediatric Exercise Science, 27(2), pp.177~184 (2015)

관련 논문AI추천